VIMTA LABS
Back to All Ratios
|
VIMTA LABS Last 5 Year Payable days History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Payable days | - | - | - | 1,549.17 | - |
What is the latest Payable days ratio of VIMTA LABS ?
Year | Payable days |
---|---|
Mar2024 | - |
Mar2023 | - |
Mar2022 | - |
Mar2021 | 1,549.17 |
Mar2020 | - |
How is Payable days of VIMTA LABS Trending?
Years | Payable days | % Change | |
---|---|---|---|
Mar2024 | 0 | 0 | |
Mar2023 | 0 | 0 | |
Mar2022 | 0 | -100.00 | |
Mar2021 | 1549.17 | 0 | |
Mar2020 | 0 | - |
Other Financial Ratios of VIMTA LABS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Payable days ratio of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹2,123.4 Cr | 4.9% | 32.6% | 116.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹435,179.0 Cr | 0.4% | 0.8% | 45.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,995.0 Cr | -1.4% | 1.2% | 62% | Stock Analytics | |
CIPLA | ₹116,890.0 Cr | -1.5% | -5.1% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,993.0 Cr | -0.7% | -1.3% | 13.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,444.9 Cr | -0.5% | 3% | 54.1% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | 4.9% |
32.6% |
116.7% |
SENSEX | 0.5% |
3.3% |
17.6% |
You may also like the below Video Courses